SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
8580269
Source:
http://linkedlifedata.com/resource/pubmed/id/8580269
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0013227
,
umls-concept:C0013295
,
umls-concept:C0087111
,
umls-concept:C0120240
,
umls-concept:C0139919
pubmed:issue
5
pubmed:dateCreated
1996-3-19
pubmed:abstractText
Ranitidine bismuth citrate (GR122311X) is a new drug which offers potential benefits in healing duodenal ulcers and prevention of relapse.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8707234
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Bismuth
,
http://linkedlifedata.com/resource/pubmed/chemical/Histamine H2 Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Ranitidine
,
http://linkedlifedata.com/resource/pubmed/chemical/ranitidine bismuth citrate
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0269-2813
pubmed:author
pubmed-author:BardhanK DKD
,
pubmed-author:DekkersC PCP
,
pubmed-author:ForsterJ KJK
,
pubmed-author:KleyWW
,
pubmed-author:LaceyL FLF
,
pubmed-author:LamS KSK
,
pubmed-author:NowakAA
,
pubmed-author:Schaffalitzky de MuckadellO BOB
,
pubmed-author:SchutzeKK
,
pubmed-author:TildesleyGG
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
497-506
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:8580269-Adult
,
pubmed-meshheading:8580269-Bismuth
,
pubmed-meshheading:8580269-Dose-Response Relationship, Drug
,
pubmed-meshheading:8580269-Double-Blind Method
,
pubmed-meshheading:8580269-Duodenal Ulcer
,
pubmed-meshheading:8580269-Female
,
pubmed-meshheading:8580269-Helicobacter Infections
,
pubmed-meshheading:8580269-Helicobacter pylori
,
pubmed-meshheading:8580269-Histamine H2 Antagonists
,
pubmed-meshheading:8580269-Humans
,
pubmed-meshheading:8580269-Logistic Models
,
pubmed-meshheading:8580269-Male
,
pubmed-meshheading:8580269-Middle Aged
,
pubmed-meshheading:8580269-Ranitidine
,
pubmed-meshheading:8580269-Treatment Outcome
pubmed:year
1995
pubmed:articleTitle
GR122311X (ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer.
pubmed:affiliation
Rotherham General Hospitals NHS Trust, UK.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Multicenter Study